SHA:688321 Revenue

In the year 2025, Shenzhen Chipscreen Biosciences had annual revenue of 910.06M CNY with 38.32% growth. Shenzhen Chipscreen Biosciences had revenue of 235.90M in the quarter ending December 31, 2025, with 33.40% growth.

Revenue

910.06M

Revenue Growth

+38.32%

P/S Ratio

14.47

Revenue / Employee

908.25K

Employees

1,002

Market Cap

13.17B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	910.06M	252.11M	38.32%
Dec 31, 2024	657.95M	134.24M	25.63%
Dec 31, 2023	523.71M	-6.23M	-1.18%
Dec 31, 2022	529.94M	99.49M	23.11%
Dec 31, 2021	430.45M	160.98M	59.74%
Dec 31, 2020	Pro	Pro	Pro
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Guobang Pharma	6.09B
Tibet Rhodiola Pharmaceutical Holding Co.	2.98B
Zhejiang Hisun Pharmaceutical	10.31B
Shanghai Shyndec Pharmaceutical	9.36B
Zhejiang Medicine	8.82B
Ningbo Menovo Pharmaceutical	1.56B
Beijing Aosaikang Pharmaceutical	1.83B
Zhejiang Jiuzhou Pharmaceutical	5.22B

Revenue Rankings